Development code · Small Molecule

STX209

STX209 is a development code for Arbaclofen, developed by Seaside Therapeutics, Inc..

Status
Phase 2 for Autism spectrum disorder
Mechanism
GABA-B receptor Agonist

Programs

Also known as

  • STX-209
  • arbaclofen
  • R-baclofen
  • (R)-baclofen
  • OS440
  • 69308-37-8
  • (3R)-4-amino-3-(4-chlorophenyl)butanoic acid

View the full Arbaclofen profile →